Intratumoral MMR Vaccine Injection in Borderline Resectable/Unresectable Pancreatic Cancer
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
By doing this study, it is the hope to learn whether an injection of the measles, mumps, rubella (MMR) vaccine developed by Merck \& Co. (Merck's M-M-R® II) into the tumor is safe and effective in making the tumor smaller.
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Wiek powyżej 18 lat
- •Potwierdzony rozpoznaniem rak trzustki w zaawansowanym stadium
- •Wcześniejsze leczenie chemioterapią i radioterapią (co najmniej 6-12 tygodni przed rozpoczęciem badania)
- •Dobry ogólny stan zdrowia (ocena ECOG 0-1)
- •Prawidłowe wyniki morfologii krwi (hemoglobina, białe krwinki, płytki krwi)
- •Prawidłowa funkcja wątroby
Simplified criteria — AI translation
Trial details
- Minimum age
- 18 Years
- Last updated (source)
- September 1, 2026
- Sex
- No restrictions
Therapies / drugs in trial
Locations (1)
University of Arkansas for Medical Sciences
Little Rock, United States
Trial contact
Joseph Holley, BS
Jennifer Faulkner, MS
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 9/2/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.